2025 Speakers

Jeremy Abbate

Scientific American

Erkang Ai

Hogan Lovells

Virginia Amann

ENTENTE Network

Bea Bakshi

C the Signs

Frank Bedu-Addo

PDS Biotechnology Corporation 

Robert Arch

Immunophotonics, Inc.

Stacy Blain

Concarlo Therapeutics Inc.

Komal Bajaj

NYC Health + Hospitals (Jacobi/NCB)

Max Bayer

Endpoints News

Bigyan Bista

 Enveda

Jay Campbell

Life Sciences Executive, CBO, CFO, & Advisory Board Member

Maria Carney

Northwell Health

Ahmet-Hamdi Çavuşoğlu

Merck Digital Sciences Studio

Gerald Commissiong

OS Therapies, Inc.

John Coster

Centers for Medicare and Medicaid Services (former)

Alice Valder Curran

Hogan Lovells

Milad Dagher

Nomic Bio

Daniel Delubac

iORGANBIO

David Ewing Duncan

Author, Journalist & Entrepreneur

E. Cartier Esham

Esham Strategies

Jessica Federer

Angelini Ventures

Mike Fisher

Oncimmune

Kirsten Flowers

Chiara Biosciences, Inc

James Flynn

Deerfield Management

David Foster

Island Pharmaceuticals Ltd.

Julie Frearson

Charles River Laboratories

Nicholas Geisse

Curi Bio, Inc.

Alice Gilman

R3 Biotechnologies

Connor Glass

Phantom Neuro

Gautam Goel

Aetherium Bio

Roger Hajjar

Mass General Brigham

Shelley Hartman

Aegle Therapeutics Corporation

Echo Hindle-Yang

MSQ Ventures

Beth Hoffman

Origami Therapeutics, Inc.

Nouhad Husseini

Regeneron Pharmaceuticals

Thomas Ichim

Immorta Bio

Ginger Johnson

Lumanity

Marc Jones

Altoida, Inc.

Konstantina Katcheves

Acadia Pharmaceuticals

Hans Keirstead

Immunis, Inc.

Bogdan Knezevic

Kaleidoscope.bio

Richard Kornbluth

Multimeric Biotherapeutics, Inc.

Akhila Kosaraju

Phare Bio

Filipp Kramer

Alchemy Bio

Michael Langer

 T.Rx Capital

Yeji Jesse Lee

 Law360

Raven Lin

Pilatus Biosciences

Neal Masia

EntityRisk, Inc.

Jeffrey Meckler

Indaptus Therapeutics

Shreefāl Mehta

Repoxegen Therapeutics Inc.

Michael Meyers

H.C. Wainwright & Co., LLC

Michael Montgomery

Tidewave Bio

Nancy Myers

Catalyst Healthcare Consulting

Jo Natauri

Invidia Capital Management

Tim Opler

Stifel

David Pass

AltrixBio Inc.

Michael D. Patten

Harbour BioMed

Kelliann Payne

Hogan Lovells

Bernard Peperstraete

Acuamark Diagnostics, Inc.

Viq Pervaaz

NYCEDC

Dan Que Pham

Oncodea

Alex Philippidis

Genetic Engineering & Biotechnology News (GEN)

Maria Luisa Pineda

Envisagenics

Aayushi Pratap

American Chemical Society

Dennis Purcell

Aisling Capital

Umer Raffat

Evercore ISI

Priyanka Rao

Rackhouse Venture Capital

Rachel Ravens

46Health

Dayton Reardan

Niche Biopharmaceuticals, LLC

MaryAnne Rizk

Amazon Web Services

Adam Rogers

NervGen Pharma

Beth Rogozinski

Oncoustics

Irene Rombel

 BioCurie

Philip Ross

Jefferies

Peter Rubin

No Patient Left Behind

Eric Schmidt

Cantor Fitzgerald

David Schull

Russo Partners

Stacey Seltzer

Pontiva Healthcare Partners

Melindah Sharma

Manatt Health

Rachel Sher

Manatt Health

Greg Simon

Former Director, White House Cancer Moonshot

Rachel Sparks

Yale University

Arun Swaminathan

Coya Therapeutics, Inc.

Daniel Teper

Naya Therapeutics

Wenzhi Tian

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Ashish Tripathi

Tzar Labs

John Tsang

Yale University

Arda Ural

Ernst & Young LLP

Brent Vaughan

Eratos Therapeutics

Chris Vlahos

Acadia Pharmaceuticals

Michael Webb

Epion Therapeutics, Inc.

Brenda Wu

Teva Pharmaceuticals

Ming-Ru Wu

 TroGen Therapeutics

Luke Yu

Crown Bioscience

Lihua Zheng

Z-Star Therapeutics Inc.

Be a part of BioFuture

© 2024 BioFutureTM. All Rights Reserved

Produced by